MeDiC  |  Metabolic Disorders and Complications Program

Our Researchers

The Metabolic Disorders and Complications Program (MeDiC) brings together a team of outstanding research scientists who share the goal of developing new diagnostic tools, treatments and health policies for obesity, diabetes and osteoporosis, along with their complications, including kidney failure, heart disease, fatty liver/cirrhosis, dementia and stroke.

More than one in three Canadians are affected by common and chronic metabolic disorders. The MeDiC Program unites multidisciplinary researchers to study these problems in both adults and children. Each member of the MeDiC program is also affiliated with at least one of the research centres at the Research Institute of the McGill University Health Centre: the Centre for Translational Biology, the Centre for Innovative Medicine and the Centre for Outcomes Research and Evaluation.

To learn more about the MeDiC program, visit our Events, News and Contact Us pages.

Filters icon icon

Displaying 22 result(s).

Andrew Bateman, PhD

Progranulin

neuroprotection

tissue repair

growth factors

cell communication

CTB

Barry Bedell, MD, PhD

Imaging

MRI

PET

image processing

neuropathology

CTB

Stéphanie Chevalier, RD, PhD

nutrition

metabolism

insulin resistance

stable isotopes

clinical and translational research

CTB

Andrey Cybulsky, MD

cell injury

glomerulonephritis

phospholipases

protein kinases

stress proteins

CTB

George Fantus, MD, FRCPC

Insulin resistance

tyrosine kinase and phosphatase

glucose metabolism

diabetes complications

oxidative stress

CTB

David Goltzman, MD

calcium and mineral metabolism

hormonal regulation

bone metabolism

osteoporosis

parathyroid disorders

CTB

Ahmad Haidar, PhD

Type 1 diabetes

clinical research

artificial pancreas systems

automated insulin delivery system

randomized controlled trials

CTB

Bertrand Jean-Claude, M.Sc., PhD

Kinase inhibitors

anti-cancer drugs

pharmacokinetics

molecular modeling

CTB

Maia Kokoeva, PhD

Obesity

diabetes

hypothalamus

leptin receptor

leptin sensing

CTB

Richard Kremer, MD, PhD

Vitamin D

Parathyroid hormone related peptide (PTHrP)

Breast cancer

skeletal metastasis

circulating tumor cells

CTB

Stéphane Laporte, PhD

G protein-coupled receptor

molecular pharmacology

cell imaging

cardiovascular diseases

pre-term birth.

CTB

Louise Larose, PhD

intracellular signaling

adaptor proteins

unfolded protein response

insulin resistance

obesity and diabetes

CTB

Serge Lemay, MD

tyrosine kinase

adaptor proteins

acute kidney injury

cell signaling

CTB

Jun-Li Liu, PhD

CCN5/WISP2

pancreatic islets

growth and development

transgenic mice

knockout mice

CTB

Errol Marliss, MD, FRCPC

Nutrition

metabolism

diabetes

obesity

insulin resistance

CTB

Steven Paraskevas, MD, PhD

islets of Langerhans

type 1 diabetes

cell death

inflammation

ischemia-reperfusion injury

CTB

Shafaat Rabbani, MD

Breast and prostate cancer

DNA methylation

proteases and growth factors

bone metastasis

cancer progression

CTB

Christian Rocheleau, PhD

epidermal growth factor receptor (EGFR)

Ras protein

Caenorhabditis elegans

Rab proteins

vesicular trafficking

CTB

Tomoko Takano, MD, PhD

nephrotic syndrome

proteinuria

podocytes

Rho-GTPases

cytoskeleton

CTB

Elena Torban, PhD

kidney development

planar cell polarity

cilia formation and ciliophaties

glomerular disease

mouse models of human kidney diseases

CTB

Jeremy Van Raamsdonk, PhD, M.Sc

aging

neurodegeneration

Parkinson's disease

Huntington's disease

mitochondria

CTB

Simon Wing, MD

ubiquitin

muscle wasting

spermatogenesis

cachexia

diabetes

CTB

Explore what the MeDiC Program has to offer